CAPTRUST Financial Advisors
TNDM icon

CAPTRUST Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
16,918
+1,877
+12% +$32.8K ﹤0.01% 2711
2026
Q1 		$288K Buy
15,041
+1,930
+15% +$41.9K ﹤0.01% 2415
2025
Q4 		$288K Buy
13,111
+860
+7% +$15.5K ﹤0.01% 2280
2025
Q3 		$149K Sell
12,251
-12,515
-51% -$169K ﹤0.01% 2468
2025
Q2 		$462K Buy
24,766
+3,249
+15% +$64.3K ﹤0.01% 1779
2025
Q1 		$412K Buy
21,517
+3,004
+16% +$87.9K ﹤0.01% 1759
2024
Q4 		$667K Buy
18,513
+8,343
+82% +$282K ﹤0.01% 1455
2024
Q3 		$431K Buy
10,170
+1,647
+19% +$69.8K ﹤0.01% 1656
2024
Q2 		$343K Buy
8,523
+686
+9% +$28.6K ﹤0.01% 1732
2024
Q1 		$278K Buy
7,837
+823
+12% +$22.1K ﹤0.01% 1816
2023
Q4 		$207K Buy
+7,014
New +$146K ﹤0.01% 2374
2022
Q3 		– Sell
-3,251
Closed -$192K – 3883
2022
Q2 		$192K Sell
3,251
-2,233
-41% -$183K ﹤0.01% 1722
2022
Q1 		$638K Buy
5,484
+1,632
+42% +$191K ﹤0.01% 1036
2021
Q4 		$580K Buy
3,852
+84
+2% +$11.3K ﹤0.01% 1045
2021
Q3 		$450K Sell
3,768
-43
-1% -$4.74K ﹤0.01% 1082
2021
Q2 		$371K Sell
3,811
-413
-10% -$36.8K ﹤0.01% 1134
2021
Q1 		$373K Buy
4,224
+2,122
+101% +$197K ﹤0.01% 1108
2020
Q4 		$201K Buy
2,102
+1
+0% +$103 ﹤0.01% 1182
2020
Q3 		$239K Buy
2,101
+51
+2% +$5.36K ﹤0.01% 959
2020
Q2 		$203K Sell
2,050
-431
-17% -$34.4K ﹤0.01% 1032
2020
Q1 		$149K Buy
+2,481
New +$174K ﹤0.01% 966
2019
Q4 		– Sell
-1,155
Closed -$68K – 1739
2019
Q3 		$68K Buy
1,155
+850
+279% +$54.3K ﹤0.01% 905
2019
Q2 		$20K Hold
305
– – ﹤0.01% 1280
2019
Q1 		$19K Buy
+305
New +$16K ﹤0.01% 1182

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

CAPTRUST Financial Advisors's TNDM Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Tandem Diabetes Care (TNDM) stake by 12% in Q2 2026, buying an estimated $32.8K and bringing the position to 16,918 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

CAPTRUST Financial Advisors first reported a position in TNDM in Q1 2019 and has held it in 24 quarters since. The position peaked at $667K in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • CAPTRUST Financial Advisors held 16,918 shares of Tandem Diabetes Care worth $255K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 1,877 Tandem Diabetes Care shares in Q2 2026, an estimated $32.8K.
  • Tandem Diabetes Care made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2711 holding.
  • CAPTRUST Financial Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 24 quarters since.
  • CAPTRUST Financial Advisors's Tandem Diabetes Care position peaked at $667K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.